Clarity Pharmaceuticals Eulerpool 뉴스

Clarity Pharmaceuticals Eulerpool-AFX

Clarity Pharmaceuticals 주식 뉴스

Clarity Pharmaceuticals는 전 세계의 많은 기자와 투자자들에게 주시되고 있습니다. 가장 최신의 Clarity Pharmaceuticals 뉴스를 여기에서 소개합니다.

• ·

  Yahoo
  Is Clarity Pharmaceuticals Ltd (ASX:CU6) Trading At A 48% Discount?
• ·

  Yahoo
  Clarity's theranostic prostate cancer trial advances to multi-dose phase
• ·

  Yahoo
  Additional COBRA results: SAR-bisPSMA detects lesions in the 2-millimetre range
• ·

  Yahoo
  First patient dosed in Clarity's registrational Phase III prostate cancer trial with Cu-64 SAR-bisPSMA
• ·

  Yahoo
  Registrational Phase III CLARIFY trial in prostate cancer commences
• ·

  Yahoo
  First patient with metastatic prostate cancer to receive 2 doses of Cu-67 SAR-bisPSMA achieves undetectable PSA level
• ·

  Yahoo
  Recruitment target achieved for Phase II SAR-Bombesin prostate cancer trial
• ·

  Yahoo
  Clarity and PSI kick off SAR-bisPSMA Phase III
• ·

  Yahoo
  First patient treated with Cu-67 SAR-Bombesin in theranostic prostate cancer trial
• ·

  Yahoo
  Clarity's theranostic prostate cancer trial advances to highest dose level